Results 231 to 240 of about 53,616 (262)
Some of the next articles are maybe not open access.

Three-Dimensional NLOS VLP Based on a Luminance Distribution Model for Image Sensor

IEEE Internet of Things Journal, 2023
Visible light positioning (VLP) is playing a critical role in delivering better location-based services. However, traditional VLP systems rely on line-of-sight (LOS) paths and have a requirement for large numbers of light-emitting diodes (LEDs) and ...
Tianming Huang   +4 more
semanticscholar   +1 more source

Using Data Pre-Processing and Convolutional Neural Network (CNN) to Mitigate Light Deficient Regions in Visible Light Positioning (VLP) Systems

Journal of Lightwave Technology, 2022
New systems and technologies, such as Internet-of-Things (IOT) may require high reliability and high accuracy indoor positioning and tracking of persons and devices in indoor areas. Among different visible-light-positioning (VLP) schemes, received-signal-
L. Hsu   +8 more
semanticscholar   +1 more source

Production and purification of hybrid Ty-VLPs

Molecular Biotechnology, 1994
This article describes how pure Ty-VLPs (virus-like particles) can be prepared from hybrid Ty-VLPs. Many different hybrid Ty-VLPs have been produced and may be easily purified. Since the sedimentation properties of different hybrid Ty-VLPs are similar, a simple purification process can be used for any VLP.
N R, Burns   +4 more
openaire   +3 more sources

Development of target‐tunable P22 VLP‐based delivery nanoplatforms using bacterial superglue

Biotechnology and Bioengineering, 2019
Protein cage nanoparticles are widely used as targeted delivery nanoplatforms, because they have well‐defined symmetric architectures, high biocompatibility, and enough plasticity to be modified to produce a range of different functionalities.
Hansol Kim   +3 more
semanticscholar   +1 more source

Biosynthesis of Glycoconjugate Virus-like Particles (VLPs)

2020
The outermost surface of bacterial pathogens consists primarily of complex carbohydrate structures-polysaccharides, glycolipids, and glycoproteins. To raise a long-lasting and effective immune response against carbohydrate antigens, they generally require covalent attachment to an immunogenic carrier protein-a so-called glycoconjugate vaccine.
Kathryn K, Oi   +2 more
openaire   +2 more sources

Experimental Demonstration of Indoor Sub-Decimeter Accuracy VLP System Using Differential PDOA

IEEE Photonics Technology Letters, 2018
In this letter, we for the first time experimentally demonstrate a sub-decimeter accuracy visible light positioning (VLP) system using a modified phase difference of arrival (PDOA) algorithm, i.e., differential PDOA (DPDOA).
S. Zhang   +3 more
semanticscholar   +1 more source

Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease

Antiviral Research, 2016
Foot and mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed animals. Previously, we found that the epitope peptide EP141-160 displayed on virus-like particles (VLP) for use as a vaccine showed high immunoreactivity and conferred partially effective protection to animals.
Yan-mei Dong   +3 more
openaire   +2 more sources

Differences in betaine lipids and fatty acids between Pseudoisochrysis paradoxa VLP and Diacronema vlkianum VLP isolates (Haptophyta)

Phytochemistry, 2013
Two Haptophytes were isolated from extensive aquaculture ponds at Veta La Palma state (Guadalquivir estuary, SW Spain). They were identified as Pseudoisochrysis paradoxa VLP and Diacronema vlkianum VLP based on their SSU rDNA homology to other Haptophytes and positioned in the Isochrysidaceae and Pavlovaceae families, respectively. Both Haptophytes had
Isabel, Armada   +5 more
openaire   +2 more sources

Subunit Protein Vaccine Delivery System for Tuberculosis Based on Hepatitis B Virus Core VLP (HBc-VLP) Particles

2016
Despite the development of modern medicine, tuberculosis (TB), caused by the pathogenic bacterium, Mycobacterium tuberculosis (Mtb), remains one of the deadliest diseases. This bacterium can lay dormant in individuals and get activated when immunity goes down and has also shown considerable prowess in mutating into drug resistant forms.
Dhananjayan, Dhanasooraj   +2 more
openaire   +2 more sources

p24-VLP

Drugs of the Future, 1993
S. Adams, G. Patou
openaire   +1 more source

Home - About - Disclaimer - Privacy